FAQs – on Ranitidine tablets and injections in India

FAQs - on Ranitidine tablets and injections in India

761
FAQs
Picture: Pixabay
Lalit Kr. Goel

Last Updated on July 19, 2021 by The Health Master

Q. What is the status of sale of Ranitidine tablet/ injection in India

Ans:
Ranitidine is a schedule H drug available in the market in the form of tablet and injections.

Govt. of India has not banned under section 26 A of the Drugs and Cosmetics Act.

As per the news from USFDA on dated 13 September 2019 that Ranitidine formulation contains N-Nitrosodimethylamine (NDMA) which is an impurity cause cancer.

So, Ranitidine manufacturer / formulators should get their products tested for the presence of impurities i.e.  N-Nitrosodimethylamine (NDMA). 

Subscribe for daily free updates

Telegram
WhatsApp
Facebook
LinkedIn

Enter your email address:

Delivered by FeedBurner